STERIS plc

STE

STERIS plc

STE

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-15Shares Purchased (TTM):0Shares Sold (TTM):51,284

Institutional Sentiment:

As of:N/AInstitutional Shares Owned:N/AShares Outstanding:N/AInstitutional Ownership Pct.:N/A

Earnings Market Reaction:

Filing Date:2026-05-29Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Orthopedic, Prosthetic & Surgical Appliances & Supplies

ISRG EW ZBH ALGN MSA ESTA

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Cash And Cash Equivalents At Carrying Value	440	424	319	280	172	155	172	198	207	196	214	209
Accounts Receivable Net Current	1,093	991	947	947	1,044	915	923	893	1,008	964	940	888
Assets Current
Assets Current	2,395	2,286	2,106	2,058	2,001	1,898	1,938	1,940	2,869	2,219	2,174	2,031
Inventory Net	632	674	659	641	581	650	689	699	675	856	821	769
Other Prepaid Expense Current	230	198	181	190	204	178	153	151	174	204	199	166
Assets Of Disposal Group Including Discontinued Op…	-	-	-	-	0	0	0	0	805	-	-	-
Property Plant And Equipment Net	2,161	2,133	2,092	2,055	1,957	1,922	1,930	1,834	1,765	1,844	1,744	1,726
Operating Lease Right Of Use Asset	155	155	161	164	156	154	159	165	173	195	192	195
Goodwill	4,195	4,232	4,215	4,223	4,096	4,044	4,151	4,057	4,071	4,112	4,040	3,887
Intangible Assets Net Excluding Goodwill	1,620	1,692	1,749	1,817	1,854	1,923	2,004	2,049	2,119	2,987	3,058	2,865
Other Assets Noncurrent	211	94	88	89	83	68	60	63	66	77	73	80
Assets	10,737	10,591	10,411	10,405	10,147	10,008	10,242	10,109	11,064	11,435	11,281	10,784
Disposal Group Including Discontinued Operation As…	-	-	-	-	-	-	-	-	0	-	-	-
Liabilities And Stockhold…
Accounts Payable Current	339	285	309	301	281	238	235	232	252	277	294	261
Accrued Income Taxes Current	29	10	17	65	22	0	6	57	14	25	32	64
Employee Related Liabilities Current	221	188	168	155	193	161	147	149	165	179	136	132
Operating Lease Liability Current	36	34	35	35	34	32	31	30	31	37	34	34
Liabilities Current
Liabilities Current	1,145	922	889	927	1,022	891	805	834	931	914	873	887
Short Term Borrowings	119	0	0	0	125	125	80	80	86	78	71	63
Accrued Liabilities Current	402	405	360	371	368	335	307	287	320	318	307	333
Liabilities Of Disposal Group Including Discontinu…	-	-	-	-	0	0	0	0	64	-	-	-
Long Term Debt Noncurrent	1,813	1,898	1,897	1,903	1,919	2,039	2,156	2,236	3,120	3,231	3,366	2,860
Deferred Income Taxes And Other Tax Liabilities No…	391	415	412	411	404	453	463	456	480	621	613	618
Operating Lease Liability Noncurrent	120	-	-	-	125	-	-	-	146	-	-	-
Other Liabilities Noncurrent	72	67	64	64	62	73	74	72	72	78	77	77
Liabilities	3,540	3,424	3,388	3,435	3,531	3,580	3,632	3,738	4,748	5,007	5,091	4,606
Liabilities Of Disposal Group Including Discontinu…	-	-	-	-	-	-	-	-	0	-	-	-
Common Stock Value	4,281	4,340	4,359	4,431	4,420	4,405	4,491	4,500	4,543	4,534	4,519	4,498
Retained Earnings Accumulated Deficit	3,016	2,857	2,726	2,597	2,475	2,386	2,268	2,178	2,088	2,134	2,046	1,981
Accumulated Other Comprehensive Income Loss Net Of…	-113	-43	-76	-71	-292	-374	-166	-323	-329	-253	-387	-311
Stockholders Equity	7,184	7,168	7,009	6,970	6,616	6,429	6,593	6,370	6,302	6,415	6,189	6,178
Minority Interest	14	13	14	13	12	12	17	16	13	13	11	10
Liabilities And Stockholders Equity	10,737	10,591	10,411	10,405	10,147	10,008	10,242	10,109	11,064	11,435	11,281	10,784
Allowance For Doubtful Accounts Receivable Current	27	29	27	26	24	22	24	24	23	28	27	24
Common Stock Par Or Stated Value Per Share	0	0.001	0.001	0.001	0	0.001	0.001	0.001	0	0.001	0.001	0.001
Common Stock Shares Authorized	500	500	500	500	500	500	500	500	500	500	500	500
Common Stock Shares Issued	489	491	-	-	492	-	-	-	494	-	-	-
Shares Outstanding	98	98	98	99	98	98	99	99	99	99	99	99

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	3.73%	5.71%	2.18%	2.39%	-1.78%	-0.21%	0.33%	-12.77%	-11.82%	-4.47%	2.71%	-
2025	0.59%	-0.03%	-6.27%	1.92%	-3.24%	0.97%	-1.52%	0.15%	1.05%	-3.58%	-7.71%	0.46%
2024	2.50%	-2.36%	-6.83%	-6.50%	1.00%	-0.72%	5.92%	2.30%	-7.22%	-2.15%	0.62%	4.23%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	2.09	2.48	2.37	2.22	1.96	2.13	2.41	2.33	3.08	2.43	2.49	2.29
Quick Ratio	1.54	1.75	1.63	1.53	1.39	1.40	1.55	1.49	2.36	1.49	1.55	1.42
Working Capital	1.25B	1.36B	1.22B	1.13B	978.60M	1.01B	1.13B	1.11B	1.94B	1.31B	1.30B	1.14B
Leverage & Debt
Debt to Equity	0.49	0.48	0.48	0.49	0.53	0.56	0.55	0.59	0.75	0.78	0.82	0.75
Interest Coverage TTM	18.15	15.94	14.53	12.91	10.04	8.27	6.81	5.79	5.79	9.82	10.34	7.06
Debt Ratio	0.33	0.32	0.33	0.33	0.35	0.36	0.35	0.37	0.43	0.44	0.45	0.43
Efficiency & Turnover
Asset Turnover TTM	0.57	0.57	0.55	0.54	0.51	0.50	0.49	0.50	0.47	0.42	0.42	0.42
Days Sales Outstanding TTM	65.70	59.68	59.87	60.27	68.60	63.53	63.87	62.07	66.53	69.64	68.24	66.05
Receivables Turnover TTM	5.56	6.12	6.10	6.06	5.32	5.75	5.72	5.88	5.49	5.24	5.35	5.53
Per Share Metrics
Diluted EPS TTM	7.93	7.17	6.96	6.54	6.20	4.76	4.41	4.04	3.82	5.70	5.52	1.20
Free Cash Flow Per Share TTM	9.90	9.34	9.77	9.24	7.89	7.63	6.89	6.01	6.20	6.01	5.42	5.00
Dividend Per Share TTM	2.46	2.40	2.34	2.28	2.23	2.19	2.13	2.08	2.03	1.98	1.94	1.89
Margin Metrics
Gross Profit Margin TTM	44.25%	44.11%	44.29%	44.13%	44.01%	43.43%	43.08%	43.20%	43.17%	43.66%	43.60%	43.65%
Operating Profit Margin TTM	18.56%	17.18%	17.07%	16.64%	15.87%	16.13%	16.00%	15.74%	16.27%	29.13%	28.87%	18.20%
Net Profit Margin TTM	13.18%	12.14%	12.06%	11.60%	11.26%	8.71%	8.22%	7.68%	7.40%	12.10%	11.94%	2.60%
Growth Metrics
Net Revenue Growth (1Y)	8.73%	7.96%	7.08%	6.42%	6.24%	15.29%	15.75%	14.72%	13.28%	-2.11%	-3.68%	-4.40%
Net Income Growth (1Y)	27.29%	50.36%	57.07%	60.81%	61.70%	-16.97%	-20.27%	238.94%	259.20%	-2,076.88%	-6,665.64%	-68.50%
EPS Growth (1Y)	27.80%	50.82%	57.54%	61.63%	62.03%	-16.72%	-20.20%	238.28%	262.49%	-2,095.17%	-6,744.34%	-68.06%
Valuation Metrics
P/E TTM	27.68	35.00	35.21	36.27	35.98	42.48	53.82	53.04	57.26	37.48	38.48	182.16
P/B TTM	3.01	3.45	3.45	3.36	3.34	3.11	3.57	3.36	3.45	3.30	3.42	3.50
P/S TTM	3.65	4.25	4.25	4.21	4.05	3.70	4.43	4.07	4.24	4.54	4.59	4.73
Market Cap	21.65B	24.76B	24.21B	23.45B	22.12B	19.99B	23.57B	21.32B	21.76B	21.24B	21.14B	21.61B
Enterprise Value	23.14B	26.23B	25.79B	25.07B	23.99B	21.99B	25.63B	23.44B	24.76B	24.35B	24.36B	24.32B
Calculated Values
Free Cash Flow TTM	972.40M	917.10M	961.20M	908.80M	778.00M	751.41M	680.12M	594.02M	612.95M	593.99M	535.44M	493.69M
Net Debt	1.49B	1.47B	1.58B	1.62B	1.87B	2.01B	2.06B	2.12B	3.00B	3.11B	3.22B	2.71B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-15Sale

Owner: Zangerle, John Adam

Title: Sr. VP, Gen Counsel, and Sec.

Shares: 1,419

Price/Share: $209.28

Value: $296,968.32

Shares Owned: 35,259

Relationship: Officer

Ownership: Direct

2026-06-05Sale

Owner: Carestio, Daniel A

Title: President and CEO

Shares: 1,374

Price/Share: $212.00

Value: $291,288.00

Shares Owned: 63,647

Relationship: Director,Officer

Ownership: Direct

2026-06-02Sale

Owner: Breeden, Richard C

Title: -

Shares: 1,481

Price/Share: $209.51

Value: $310,284.31

Shares Owned: 38,964

Relationship: Director

Ownership: Direct

2026-03-05Sale

Owner: Feldmann, Cynthia L

Title: -

Shares: 3,098

Price/Share: $237.21

Value: $734,876.58

Shares Owned: 705

Relationship: Director

Ownership: Direct

2025-11-21Sale

Owner: Madsen, Julia

Title: Sr. VP and GM, Life Sciences

Shares: 5,008

Price/Share: $262.00

Value: $1,312,096.00

Shares Owned: 10,710

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-15	Zangerle, John Adam	Officer	Sr. VP, Gen Counsel, and Sec.	Direct	Sale	1,419	209.28	$296,968.32	35,259	4
2026-06-05	Carestio, Daniel A	Director,Officer	President and CEO	Direct	Sale	1,374	212.00	$291,288.00	63,647	4
2026-06-02	Breeden, Richard C	Director	-	Direct	Sale	1,481	209.51	$310,284.31	38,964	4
2026-03-05	Feldmann, Cynthia L	Director	-	Direct	Sale	3,098	237.21	$734,876.58	705	4
2025-11-21	Madsen, Julia	Officer	Sr. VP and GM, Life Sciences	Direct	Sale	5,008	262.00	$1,312,096.00	10,710	4
2025-11-18	Tamaro, Renato	Officer	V.P. & Corporate Treasurer	Direct	Sale	5,036	257.74	$1,297,978.64	5,695	4
2025-11-11	Zangerle, John Adam	Officer	Sr. VP, Gen Counsel, and Sec.	Direct	Sale	15,000	265.14	$3,977,100.00	33,669	4
2025-10-06	Carestio, Daniel A	Director,Officer	President and CEO	Direct	Sale	159	241.82	$38,449.38	51,096	4
2025-08-20	Tamaro, Renato	Officer	V.P. & Corporate Treasurer	Direct	Sale	3,204	249.24	$798,564.96	7,221	4
2025-08-11	Burton, Karen L	Officer	VP & CAO	Direct	Sale	7,900	241.73	$1,909,667.00	5,994	4
2025-08-11	Sohi, Mohsen	Director	-	Direct	Sale	4,110	241.96	$994,455.60	22,361	4
2025-08-11	Feldmann, Cynthia L	Director	-	Direct	Sale	3,495	241.56	$844,252.20	705	4
2025-06-13	Zangerle, John Adam	Officer	Sr. VP, Gen Counsel, and Sec.	Direct	Sale	1,978	241.12	$476,935.36	33,760	4
2025-06-05	Carestio, Daniel A	Director,Officer	President and CEO	Direct	Sale	17,626	242.67	$4,277,301.42	51,385	4
2025-05-20	Majors, Cary L	Officer	SVP and President, Healthcare	Direct	Sale	12,828	250.22	$3,209,822.16	11,372	4
2024-11-25	Majors, Cary L	Officer	SVP and President, Healthcare	Direct	Sale	1,682	217.32	$365,532.24	11,372	4
2024-09-16	Tokich, Michael J	Officer	Sr. Vice Pres., CFO	Direct	Sale	20,213	245.24	$4,957,036.12	42,930	4
2024-09-10	Tokich, Michael J	Officer	Sr. Vice Pres., CFO	Direct	Sale	23,332	247.00	$5,763,004.00	42,930	4
2024-08-08	Holland, Christopher S	Director	-	Direct	Sale	473	239.68	$113,368.64	582	4
2024-06-05	Madsen, Julia	Officer	Senior VP, Life Sciences	Direct	Sale	3,652	230.00	$839,960.00	9,671	4
2024-06-05	Majors, Cary L	Officer	SVP and President, Healthcare	Direct	Sale	4,932	229.63	$1,132,535.16	13,054	4
2024-05-16	Tamaro, Renato	Officer	V.P. & Corporate Treasurer	Direct	Sale	1,154	231.64	$267,312.56	6,677	4
2024-05-15	Tokich, Michael J	Officer	Sr. Vice Pres., CFO	Direct	Sale	32,000	234.98	$7,519,360.00	42,464	4
2024-05-15	Feldmann, Cynthia L	Director	-	Direct	Sale	2,000	237.65	$475,300.00	705	4
2024-05-14	Burton, Karen L	Officer	VP & CAO	Direct	Sale	3,000	235.95	$707,850.00	3,759	4
2024-05-14	Sohi, Mohsen	Director	-	Direct	Sale	2,037	233.50	$475,639.50	22,361	4
2024-05-13	Kosecoff, Jacqueline B	Director	-	Direct	Sale	4,584	231.53	$1,061,333.52	0	4
2024-05-13	Majors, Cary L	Officer	SVP and President, Healthcare	Direct	Sale	2,024	232.13	$469,831.12	11,369	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

No institutional ownership data available.

STERIS plc (STE) — SEC Financial Statements & Analysis

STERIS plc (STE) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in L2. STERIS plc trades on STE: NYSE as: STE. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), STERIS plc reported a 8.73% year-over-year revenue growth, a Gross Profit Margin of 44.25% (TTM), a Debt-to-Equity ratio of 0.49x, a Price-to-Sales (P/S) ratio of 3.65x (TTM), a Price-to-Book (P/B) ratio of 3.01 (TTM), at a market cap of $21.65B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 8.73%
Gross Profit Margin TTM: 44.25%
Debt To Equity: 0.49x
P/S TTM: 3.65x
P/B TTM: 3.01
Market Cap: $21.65B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is STERIS plc in?

STERIS plc (STE) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.

What is STE's market cap?

STERIS plc (STE) has a market capitalization of $21.65B as of 2026-03-31.

What is STE's P/E ratio?

STERIS plc (STE)'s trailing twelve month P/E ratio is 27.68x as of 2026-03-31.

What exchange does STE trade on?

STERIS plc (STE) trades on the STE: NYSE.

Where is STERIS plc incorporated?

STERIS plc is incorporated in Ireland.

STERIS plc (STE) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.